Devyser Diagnostics AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was SEK 30.9 million compared to SEK 21.8 million a year ago. Net loss was SEK 14.3 million compared to SEK 6.2 million a year ago. Basic loss per share from continuing operations was SEK 0.9 compared to SEK 0.55 a year ago. Diluted loss per share from continuing operations was SEK 0.9 compared to SEK 0.55 a year ago.
For the six months, sales was SEK 61.3 million compared to SEK 44.6 million a year ago. Net loss was SEK 20.4 million compared to SEK 6.5 million a year ago. Basic loss per share from continuing operations was SEK 1.29 compared to SEK 0.61 a year ago. Diluted loss per share from continuing operations was SEK 1.29 compared to SEK 0.61 a year ago.